Gilead Sciences (GILD) Stock Forecast for 2023 – 2026. Sell or Buy Prediction

Gilead Sciences (GILD) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: December 5, 2023 (14:09)

Sector: Healthcare

The share price of Gilead Sciences, Inc. (GILD) now

Latest session on the 5th of December for
Gilead Sciences, Inc. is positive
Trading Volume: 6277013
Open: 78.37 /  High: 79.275 /  Low: 77.845
What analysts predict: $89.76
52-week High/Low: $86.75 / $72.54

50/200 Day Moving Average: $76.7 / $78.37

This figure corresponds to the Average Price over the previous 50/200 days. For Gilead Sciences stocks, the 50-day moving average is the support level today.

For Gilead Sciences stocks, the 200-day moving average is the resistance level today.

Are you interested in Gilead Sciences, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Gilead Sciences stock price in 2024, 2025, 2026, 2027, 2028. How much will one Gilead Sciences share be worth in 2024 - 2028?

When should I take profit in Gilead Sciences stock? When should I record a loss on Gilead Sciences stock? What are analysts' forecasts for Gilead Sciences stock? What is the future of Gilead Sciences stock? We forecast Gilead Sciences stock performance using neural networks based on historical data on Gilead Sciences stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Gilead Sciences stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Gilead Sciences shares. This happens once a day.




Historical and forecast chart of Gilead Sciences stock

The chart below shows the historical price of Gilead Sciences stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Gilead Sciences stock price can be found in the table below.

Long-term forecasts by years.

Gilead Sciences is an American biopharmaceutical company that discovers, develops and markets innovative medicines. For many years since the firm opened, they have specialized mainly in antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C and influenza. The company is headquartered in Foster City, California, but has offices in North America, Europe and Australia.

Gilead Sciences was founded in June 1987 by a young physician, Michael Riordan. Michael worked with three key scientific advisors to start the company – Peter Derwan of the California Institute of Technology, Doug Melton of Harvard, and Harold Weintraub of the Fred Hutchinson Cancer Research Center. Riordan served as CEO from inception until 1996. He was most interested in the antiviral business, as he contracted dengue himself. In 2006, the company made two acquisitions, which allowed it to expand into not only antiviral drugs, but also drugs in the field of cardiovascular and respiratory diseases.

Official site of the company

Gilead Sciences daily forecast for a month

Date Target Pes. Opt. Vol., %
Dec 07 78.82 78.52 79.19 0.84
Dec 08 79.13 78.69 79.63 1.19
Dec 09 78.36 77.83 78.70 1.11
Dec 10 78.19 78.00 78.55 0.70
Dec 11 78.90 78.66 79.32 0.84
Dec 12 79.44 78.72 79.79 1.36
Dec 13 79.29 78.99 79.55 0.71
Dec 14 78.92 78.41 79.66 1.59
Dec 15 79.01 78.35 79.20 1.09
Dec 16 79.28 78.57 79.89 1.68
Dec 17 79.31 78.84 79.63 1.00
Dec 18 79.77 79.35 80.16 1.01
Dec 19 79.80 79.58 80.33 0.94
Dec 20 80.08 79.78 80.82 1.30
Dec 21 80.05 79.83 80.40 0.71
Dec 22 79.79 79.56 80.45 1.11
Dec 23 80.04 79.57 80.42 1.06
Dec 24 79.61 79.32 80.11 0.99
Dec 25 78.91 78.19 79.28 1.39
Dec 26 78.35 77.80 78.66 1.10
Dec 27 77.97 77.69 78.70 1.30
Dec 28 78.34 78.01 79.05 1.33
Dec 29 77.94 77.36 78.24 1.14
Dec 30 78.44 77.87 79.07 1.54
Dec 31 79.02 78.54 79.33 1.00
Jan 01 79.08 78.33 79.61 1.64
Jan 02 78.45 78.06 79.20 1.46
Jan 03 78.11 77.75 78.84 1.40
Jan 04 78.45 78.09 78.81 0.93
Jan 05 77.78 77.49 77.97 0.61

Gilead Sciences Daily Price Targets


Gilead Sciences Stock Forecast 12-07-2023.

Forecast target price for 12-07-2023: $78.82.
Positive dynamics for Gilead Sciences shares will prevail with possible volatility of 0.836%.
Pessimistic target level: 78.52
Optimistic target level: 79.19

Gilead Sciences Stock Forecast 12-08-2023.

Forecast target price for 12-08-2023: $79.13.
Positive dynamics for Gilead Sciences shares will prevail with possible volatility of 1.181%.
Pessimistic target level: 78.69
Optimistic target level: 79.63

Gilead Sciences Stock Forecast 12-09-2023.

Forecast target price for 12-09-2023: $78.36.
Negative dynamics for Gilead Sciences shares will prevail with possible volatility of 1.099%.
Pessimistic target level: 77.83
Optimistic target level: 78.70

Gilead Sciences Stock Forecast 12-10-2023.

Forecast target price for 12-10-2023: $78.19.
Negative dynamics for Gilead Sciences shares will prevail with possible volatility of 0.693%.
Pessimistic target level: 78.00
Optimistic target level: 78.55

Gilead Sciences Stock Forecast 12-11-2023.

Forecast target price for 12-11-2023: $78.90.
Positive dynamics for Gilead Sciences shares will prevail with possible volatility of 0.835%.
Pessimistic target level: 78.66
Optimistic target level: 79.32

Gilead Sciences Stock Forecast 12-12-2023.

Forecast target price for 12-12-2023: $79.44.
Positive dynamics for Gilead Sciences shares will prevail with possible volatility of 1.338%.
Pessimistic target level: 78.72
Optimistic target level: 79.79

GILD (GILD) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan. 78.98 76.36 80.51 5.15
Feb. 82.89 82.00 85.25 3.82
Mar. 83.77 82.66 86.17 4.07
Apr. 81.25 79.51 83.49 4.76
May. 82.83 79.45 85.62 7.20
Jun. 86.80 84.90 89.76 5.42
Jul. 90.65 88.38 93.05 5.02
Aug. 89.63 87.35 90.78 3.78
Sep. 90.14 89.12 92.25 3.39
Oct. 93.58 90.62 95.40 5.00
Nov. 92.68 90.69 94.80 4.34
Dec. 93.48 92.53 95.05 2.66

Gilead Sciences forecast for this year


Gilead Sciences Stock Prediction for Jan 2024

An uptrend is forecast for this month with an optimal target price of $78.9793. Pessimistic: $76.36. Optimistic: $80.51


Gilead Sciences Stock Prediction for Feb 2024

An uptrend is forecast for this month with an optimal target price of $82.8864. Pessimistic: $82.00. Optimistic: $85.25


Gilead Sciences Stock Prediction for Mar 2024

An uptrend is forecast for this month with an optimal target price of $83.7741. Pessimistic: $82.66. Optimistic: $86.17


Gilead Sciences Stock Prediction for Apr 2024

An downtrend is forecast for this month with an optimal target price of $81.2533. Pessimistic: $79.51. Optimistic: $83.49


Gilead Sciences Stock Prediction for May 2024

An uptrend is forecast for this month with an optimal target price of $82.828. Pessimistic: $79.45. Optimistic: $85.62


Gilead Sciences Stock Prediction for Jun 2024

An uptrend is forecast for this month with an optimal target price of $86.7988. Pessimistic: $84.90. Optimistic: $89.76


Gilead Sciences Stock Prediction for Jul 2024

An uptrend is forecast for this month with an optimal target price of $90.65. Pessimistic: $88.38. Optimistic: $93.05


Gilead Sciences Stock Prediction for Aug 2024

An downtrend is forecast for this month with an optimal target price of $89.6329. Pessimistic: $87.35. Optimistic: $90.78


Gilead Sciences Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $90.1358. Pessimistic: $89.12. Optimistic: $92.25


Gilead Sciences Stock Prediction for Oct 2024

An uptrend is forecast for this month with an optimal target price of $93.5835. Pessimistic: $90.62. Optimistic: $95.40


Gilead Sciences Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $92.6767. Pessimistic: $90.69. Optimistic: $94.80


Gilead Sciences Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $93.4802. Pessimistic: $92.53. Optimistic: $95.05



Gilead Sciences (GILD) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 93.91 92.62 96.21 3.73
Feb 95.49 92.08 96.85 4.93
Mar 97.00 93.09 99.18 6.14
Apr 101.50 99.53 105.07 5.27
May 98.96 96.09 100.83 4.71
Jun 102.95 99.22 104.84 5.36
Jul 101.64 98.58 102.78 4.09
Aug 103.66 102.45 106.62 3.92
Sep 101.60 99.42 103.78 4.19
Oct 100.46 98.31 104.05 5.52
Nov 96.26 94.44 97.24 2.88
Dec 95.13 93.92 98.96 5.10

Gilead Sciences (GILD) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 95.23 93.19 98.82 5.70
Feb 93.91 90.75 96.64 6.10
Mar 94.25 90.69 95.36 4.89
Apr 91.03 90.10 92.14 2.22
May 86.99 85.22 89.70 5.00
Jun 88.59 85.20 89.63 4.94
Jul 87.77 84.42 90.42 6.63
Aug 86.57 83.87 89.52 6.31
Sep 85.37 84.42 86.42 2.32
Oct 88.03 85.56 90.41 5.36
Nov 88.16 86.55 90.95 4.84
Dec 88.66 86.67 90.92 4.67

Gilead Sciences (GILD) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 91.46 87.87 93.23 5.75
Feb 92.91 89.92 95.47 5.81
Mar 96.89 94.76 98.96 4.24
Apr 98.77 97.00 100.13 3.12
May 96.80 93.49 100.50 6.97
Jun 96.26 92.68 97.88 5.32
Jul 95.96 94.06 97.82 3.85
Aug 95.47 91.82 98.15 6.45
Sep 100.25 98.25 101.27 2.98
Oct 104.64 102.19 107.69 5.10
Nov 108.27 105.07 112.41 6.53
Dec 111.75 107.25 114.54 6.37

Gilead Sciences (GILD) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 113.40 110.80 116.30 4.73
Feb 112.13 110.93 116.71 4.95
Mar 110.99 107.99 113.25 4.65
Apr 113.59 112.43 116.49 3.48
May 110.99 107.08 113.59 5.73
Jun 106.97 104.40 109.91 5.01
Jul 106.86 103.15 108.22 4.68
Aug 108.66 107.44 112.65 4.62
Sep 108.05 104.91 110.75 5.27
Oct 105.73 104.22 107.35 2.91
Nov 110.32 106.83 111.89 4.52
Dec 107.56 105.91 111.95 5.39

Gilead Sciences information and performance

Gilead Sciences Address

333 LAKESIDE DR, FOSTER CITY, CA, US

Market Capitalization: 96 755 016 000 $

Market capitalization of the Gilead Sciences, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of GILD shares in the company outstanding by the market price of one share.

EBITDA: 11 738 000 000 $

EBITDA of Gilead Sciences is earnings before interest, income tax and depreciation of assets.

PE Ratio: 16.63

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 0.53

Price/earnings to growth

DPS: 2.98

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.0386

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 4.67

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 0.218
Quarterly Revenue Growth YOY: 0.001
Trailing PE: 16.63

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 10.72

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 4.194

Enterprise Value (EV) /Revenue

EV To EBITDA: 10.75

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 1246040000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Gilead Sciences (GILD) stock dividend

Gilead Sciences last paid dividends on 12/14/2023. The next scheduled payment will be on 12/28/2023. The amount of dividends is $2.98 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.